Specific intronic p53 mutation in esophageal squamous cell carcinoma in southern thailand

World Journal of Gastroenterology

Volumn 16, Issue 42, 2010, Pages 5359-5366

  Thongsuksai, Paramee ^a   Boonyaphiphat, Pleumjit ^a   Puttawibul, Puttisak ^a   Sudhikaran, Wanna ^a  

^a PRINCE OF SONGKLA UNIVERSITY   (Thailand)

Author keywords

Esophageal cancer; Germline mutation; Intron; Mutation; P53 gene; Squamous cell carcinoma

Indexed keywords

NUCLEOTIDE; PROTEIN P53;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; BETEL NUT; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; EXON; FEMALE; GENE MUTATION; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE STRAND CONFORMATION POLYMORPHISM; SMOKING; THAILAND;

EID: 78649428541     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v16.i42.5359     Document Type: Article

References (35)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108
2. Hashibe M, Boffetta P, Janout V, Zaridze D, Shangina O, Mates D, Szeszenia-Dabrowska N, Bencko V, Brennan P. Esophageal cancer in Central and Eastern Europe: tobacco and alcohol. Int J Cancer 2007; 120: 1518-1522
3. Xu XC. Risk factors and gene expression in esophageal cancer. Methods Mol Biol 2009; 471: 335-360
4. Hu N, Dawsey SM, Wu M, Bonney GE, He LJ, Han XY, Fu M, Taylor PR. Familial aggregation of oesophageal cancer in Yangcheng County, Shanxi Province, China. Int J Epidemiol 1992; 21: 877-882
5. Castellsagué X, Muñoz N, De Stefani E, Victora CG, Castelletto R, Rolón PA. Influence of mate drinking, hot beverages and diet on esophageal cancer risk in South America. Int J Cancer 2000; 88: 658-664
6. Kamangar F, Chow WH, Abnet CC, Dawsey SM. Environmental causes of esophageal cancer. Gastroenterol Clin North Am 2009; 38: 27-57, vii
7. Islami F, Malekshah AF, Kimiagar M, Pourshams A, Wakefield J, Goglani G, Rakhshani N, Nasrollahzadeh D, Salahi R, Semnani S, Saadatian-Elahi M, Abnet CC, Kamangar F, Dawsey SM, Brennan P, Boffetta P, Malekzadeh R. Patterns of food and nutrient consumption in northern Iran, a highrisk area for esophageal cancer. Nutr Cancer 2009; 61: 475-483
8. Khuhaprema T, Srivatanakul P, Sriplung H, Wiangnon S, Sumitsawan Y, Attasara P. Cancer in Thailand. Vol IV, 1998-2000. Bangkok: Ministry of Public Health, 2007
9. Boonyaphiphat P, Thongsuksai P, Sriplung H, Puttawibul P. Lifestyle habits and genetic susceptibility and the risk of esophageal cancer in the Thai population. Cancer Lett 2002; 186: 193-199
10. Hollstein M, Sidransky D, Vogelstein B, Harris CC. p53 mutations in human cancers. Science 1991; 253: 49-53
11. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994; 54: 4855-4878
12. Suwiwat S, Oda H, Shimizu Y, Ishikawa T. Prevalence of p53 mutations and protein expression in esophageal cancers in southern Thailand. Int J Cancer 1997; 72: 23-26
13. Tanière P, Martel-Planche G, Puttawibul P, Casson A, Montesano R, Chanvitan A, Hainaut P. TP53 mutations and MDM2 gene amplification in squamous-cell carcinomas of the esophagus in south Thailand. Int J Cancer 2000; 88: 223-227
14. Hu N, Huang J, Emmert-Buck MR, Tang ZZ, Roth MJ, Wang C, Dawsey SM, Li G, Li WJ, Wang QH, Han XY, Ding T, Giffen C, Goldstein AM, Taylor PR. Frequent inactivation of the TP53 gene in esophageal squamous cell carcinoma from a high-risk population in China. Clin Cancer Res 2001; 7: 883-891
15. Robert V, Michel P, Flaman JM, Chiron A, Martin C, Charbonnier F, Paillot B, Frebourg T. High frequency in esophageal cancers of p53 alterations inactivating the regulation of genes involved in cell cycle and apoptosis. Carcinogenesis 2000; 21: 563-565
16. Pütz A, Hartmann AA, Fontes PR, Alexandre CO, Silveira DA, Klug SJ, Rabes HM. TP53 mutation pattern of esophageal squamous cell carcinomas in a high risk area (Southern Brazil): role of life style factors. Int J Cancer 2002; 98: 99-105
17. Gamieldien W, Victor TC, Mugwanya D, Stepien A, Gelderblom WC, Marasas WF, Geiger DH, van Helden PD. p53 and p16/CDKN2 gene mutations in esophageal tumors from a high-incidence area in South Africa. Int J Cancer 1998; 78: 544-549
18. Egashira A, Morita M, Kakeji Y, Sadanaga N, Oki E, Honbo T, Ohta M, Maehara Y. p53 gene mutations in esophageal squamous cell carcinoma and their relevance to etiology and pathogenesis: results in Japan and comparisons with other countries. Cancer Sci 2007; 98: 1152-1156
19. Condie A, Eeles R, Borresen AL, Coles C, Cooper C, Prosser J. Detection of point mutations in the p53 gene: comparison of single-strand conformation polymorphism, constant denaturant gel electrophoresis, and hydroxylamine and osmium tetroxide techniques. Hum Mutat 1993; 2: 58-66
20. Bennett WP, von Brevern MC, Zhu SM, Bartsch H, Muehlbauer KR, Hollstein MC. p53 mutations in esophageal tumors from a high incidence area of China in relation to patient diet and smoking history. Cancer Epidemiol Biomarkers Prev 1997; 6: 963-966
21. Ralhan R, Arora S, Chattopadhyay TK, Shukla NK, Mathur M. Circulating p53 antibodies, p53 gene mutational profile and product accumulation in esophageal squamous-cell carcinoma in India. Int J Cancer 2000; 85: 791-795
22. Hollstein MC, Peri L, Mandard AM, Welsh JA, Montesano R, Metcalf RA, Bak M, Harris CC. Genetic analysis of human esophageal tumors from two high incidence geographic areas: frequent p53 base substitutions and absence of ras mutations. Cancer Res 1991; 51: 4102-4106
23. Holliday R, Grigg GW. DNA methylation and mutation. Mutat Res 1993; 285: 61-67
24. Horsfall MJ, Gordon AJ, Burns PA, Zielenska M, van der Vliet GM, Glickman BW. Mutational specificity of alkylating agents and the influence of DNA repair. Environ Mol Mutagen 1990; 15: 107-122
25. Murtaza I, Mushtaq D, Margoob MA, Dutt A, Wani NA, Ahmad I, Bhat ML. A study on p53 gene alterations in esophageal squamous cell carcinoma and their correlation to common dietary risk factors among population of the Kashmir valley. World J Gastroenterol 2006; 12: 4033-4037
26. Rivenson A, Hoffmann D, Prokopczyk B, Amin S, Hecht SS. Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines. Cancer Res 1988; 48: 6912-6917
27. Thongsuksai P, Boonyaphiphat P, Sriplung H, Sudhikaran W. p53 mutations in betel-associated oral cancer from Thailand. Cancer Lett 2003; 201: 1-7
28. Petitjean A, Mathe E, Kato S, Ishioka C, Tavtigian SV, Hainaut P, Olivier M. Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database. Hum Mutat 2007; 28: 622-629
29. Chan WY, Chan EK, Chow JH. Epstein-Barr virus-associated gastric lymphomas are distinct from mucosa-associated lymphoid tissue-type lymphomas: genetic abnormalities of p53 gene. Diagn Mol Pathol 2001; 10: 153-160
30. Le Calvez F, Mukeria A, Hunt JD, Kelm O, Hung RJ, Tanière P, Brennan P, Boffetta P, Zaridze DG, Hainaut P. TP53 and KRAS mutation load and types in lung cancers in relation to tobacco smoke: distinct patterns in never, former, and current smokers. Cancer Res 2005; 65: 5076-5083
31. Lozano G, Levine AJ. Tissue-specific expression of p53 in transgenic mice is regulated by intron sequences. Mol Carcinog 1991; 4: 3-9
32. Lehman TA, Haffty BG, Carbone CJ, Bishop LR, Gumbs AA, Krishnan S, Shields PG, Modali R, Turner BC. Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer. Cancer Res 2000; 60: 1062-1069
33. Moore LE, Smith AH, Eng C, DeVries S, Kalman D, Bhargava V, Chew K, Ferreccio C, Rey OA, Hopenhayn C, Biggs ML, Bates MN, Waldman FM. P53 alterations in bladder tumors from arsenic and tobacco exposed patients. Carcinogenesis 2003; 24: 1785-1791
34. Saeki H, Ohno S, Araki K, Egashira A, Kawaguchi H, Ikeda Y, Morita M, Kitamura K, Sugimachi K. Alcohol consumption and cigarette smoking in relation to high frequency of p53 protein accumulation in oesophageal squamous cell carcinoma in the Japanese. Br J Cancer 2000; 82: 1892-1894
35. Gaur D, Arora S, Mathur M, Nath N, Chattopadhaya TK, Ralhan R. High prevalence of p53 gene alterations and protein overexpression in human esophageal cancer: correlation with dietary risk factors in India. Clin Cancer Res 1997; 3: 2129-2136